Literature DB >> 2888575

The hydra GSH receptor. Pharmacological and radioligand binding studies.

G Venturini1.   

Abstract

1. The GSH-induced feeding response of hydra has been studied using pharmacological and biochemical methods. 2. Dopaminergic agonists inhibit the response, whereas dopaminergic blocking agents increase it. Phosphodiesterase inhibitors completely inhibit the feeding response. 3. The specific binding of the competitive inhibitor of feeding response, [3H]glutamate, to hydra cellular fractions has been evaluated, and a strong GSH-sensitive binding has been observed in a nematocyst-rich fraction. 4. After pharmacological reduction of the nematocyst number, both feeding response and glutamate binding are severely reduced. 5. Ca2+ ions must be present for the feeding response to occur, whereas glutamate binding occurs both without Ca2+ and in the presence of EDTA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888575     DOI: 10.1016/0742-8413(87)90015-6

Source DB:  PubMed          Journal:  Comp Biochem Physiol C        ISSN: 0742-8413


  5 in total

1.  Nematocytes' activation in Pelagia noctiluca (Cnidaria, Scyphozoa) oral arms.

Authors:  R Morabito; A Marino; G La Spada
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2012-04-20       Impact factor: 1.836

2.  Evidence that polycystins are involved in Hydra cnidocyte discharge.

Authors:  Susan McLaughlin
Journal:  Invert Neurosci       Date:  2017-01-11

3.  Nitric oxide involvement in Hydra vulgaris very primitive olfactory-like system.

Authors:  M Colasanti; G Venturini; A Merante; G Musci; G M Lauro
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

4.  Measuring glutathione-induced feeding response in hydra.

Authors:  Ram Kulkarni; Sanjeev Galande
Journal:  J Vis Exp       Date:  2014-11-16       Impact factor: 1.355

5.  High adenylyl cyclase activity and in vivo cAMP fluctuations in corals suggest central physiological role.

Authors:  K L Barott; Y Helman; L Haramaty; M E Barron; K C Hess; J Buck; L R Levin; M Tresguerres
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.